Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Cochrane Database Syst Rev. 2011;6:CD006466
Authors: Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Terrenato I, Sperati F, Schünemann H
A number of basic research and clinical studies have led to the hypothesis that oral anticoagulants may improve the survival of patients with cancer through an antitumor effect in addition to their antithrombotic effect.
PMID: 21678357 [PubMed - in process]